A very cool link for all inhibitors t... - Advanced Prostate...

Advanced Prostate Cancer

22,015 members27,612 posts

A very cool link for all inhibitors that you can download

KocoPr profile image
3 Replies

Here is a very cool link on all the inhibitors.

This link is awesome and it covers all inhibitors for all of the cancer pathways.

Half way down under "Other Androgen Receptor Products" you will see two graphics; one is "Download Inhibitor Catalog", the other is download the "Androgen Receptor Signaling Map"

selleckchem.com/products/ra...

Related Compound Libraries

Kinase Inhibitor Library FDA-approved Drug Library Natural Product Library Bioactive Compound Library-I Bioactive Compound Library-Ⅱ Highly Selective Inhibitor Library Stem Cell Differentiation Compound Library

Other Androgen Receptor Products

Darolutamide (ODM-201, BAY-1841788) is a novel androgen receptor (AR) antagonist that blocks AR nuclear translocation with Ki of 11 nM. Phase 3.

Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.

Endoxifen HCl, the active metabolite of Tamoxifen, ia a potent and selective estrogen receptor antagonist. Phase 2.

Enzalutamide (MDV3100) is an androgen-receptor (AR) antagonist with IC50 of 36 nM in LNCaP cells. Enzalutamide is shown to increase autophagy.

Bicalutamide (ICI-176334) is an androgen receptor (AR) antagonist with IC50 of 0.16 μM in LNCaP/AR(cs)cell line. Bicalutamide promotes autophagy.

Apalutamide (ARN-509) is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM in a cell-free assay, useful for prostate cancer treatment. Phase 3.

Dehydroepiandrosterone (DHEA, Prasterone, Dehydroisoandrosterone) is an important endogenous steroid hormone, which is an androgen receptor antagonist and an estrogen receptor agonist.

Galeterone (TOK-001) is a selective CYP17 inhibitor and androgen receptor (AR) antagonist with IC50 of 300 nM and 384 nM, respectively, and is a potent inhibitor of human prostate tumor growth. Phase 2.

Ostarine (GTx-024, MK-2866) is a selective androgen receptor modulator (SARM) with Ki of 3.8 nM, and is tissue-selective for anabolic organs. Phase 3.

Flutamide (SCH-13521) is an antiandrogen drug, with its active metablolite binding at androgen receptor with Ki values of 55 nM,

Much more info

Written by
KocoPr profile image
KocoPr
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Fiddler2004 profile image
Fiddler2004

thanks for sharing this info... 🙏

KocoPr profile image
KocoPr

Anyone know which program can be used for the download of the “inhibitor catalog “ ?That is i want to click on the index references to jump to the speciclfic page but it doesn’t work with my programs

garyjp9 profile image
garyjp9

Thanks. Interesting that it does not include Abiraterone, unless I missed it.

Not what you're looking for?

You may also like...

FDA Grants Priority Review to Apalutamide ...

... based on data from the phase III SPARTAN trial (ARN-509-003) News item [1]. Apalutamide may be...

Melatonin & AR-V7

New study below. AR-V7 [Androgen Receptor Splice Variant-7] is an Androgen Receptor [AR] mutation...

Melatonin - AR-V7 Splice Variant.

The study below [1] is a cell study from last year. I don't think it has been posted before. As...

Androgen Receptor [AR] Degradation.

Ralph1966 has recently posted someting on DpC. To date, AR-axis targeted therapies have involved...

Results:Ibuprofen was significantly more effective against human prostate cancer cells in vitro than the other tested nonprescription NSAID

"MTT analysis indicated that clinically relevant concentrations of ibuprofen significantly reduced...